Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Accuracy of left ventricular ejection fraction by contemporary multiple gated acquisition scanning in patients with cancer: comparison with cardiovascular magnetic resonance.

Huang H, Nijjar PS, Misialek JR, Blaes A, Derrico NP, Kazmirczak F, Klem I, Farzaneh-Far A, Shenoy C.

J Cardiovasc Magn Reson. 2017 Mar 24;19(1):34. doi: 10.1186/s12968-017-0348-4.

2.

Adjuvant chemotherapy and HER-2-directed therapy for early-stage breast cancer in the elderly.

Sun J, Chia S.

Br J Cancer. 2017 Jan 3;116(1):4-9. doi: 10.1038/bjc.2016.360. Epub 2016 Nov 22.

3.

Potential Therapeutic Strategies for Hypertension-Exacerbated Cardiotoxicity of Anticancer Drugs.

Kuriakose RK, Kukreja RC, Xi L.

Oxid Med Cell Longev. 2016;2016:8139861. Epub 2016 Oct 17. Review.

4.

Serum B-type natriuretic peptide levels as a marker for anthracycline-induced cardiotoxicity.

Wang YD, Chen SX, Ren LQ.

Oncol Lett. 2016 May;11(5):3483-3492. Epub 2016 Apr 7.

5.

The Crossroads of Geriatric Cardiology and Cardio-Oncology.

Nguyen KL, Alrezk R, Mansourian PG, Naeim A, Rettig MB, Lee CC.

Curr Geriatr Rep. 2015;4(4):327-337. Epub 2015 Sep 16. Review.

6.

Illuminating anthracycline cardiotoxicity: the renaissance of evidence-based onco-cardiology.

Rhea IB, Oliveira GH.

J Thorac Dis. 2015 Jul;7(7):1111-2. doi: 10.3978/j.issn.2072-1439.2015.07.16. No abstract available.

7.

Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer.

Riseberg D.

Clin Med Insights Oncol. 2015 Aug 24;9:65-73. doi: 10.4137/CMO.S26067. eCollection 2015. Review.

8.

Optimal management of breast cancer in the elderly patient: current perspectives.

Le Saux O, Ripamonti B, Bruyas A, Bonin O, Freyer G, Bonnefoy M, Falandry C.

Clin Interv Aging. 2015 Jan 6;10:157-74. doi: 10.2147/CIA.S50670. eCollection 2015. Review.

9.

Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients.

Mina A, Rafei H, Khalil M, Hassoun Y, Nasser Z, Tfayli A.

BMC Cancer. 2015 Jan 21;15:10. doi: 10.1186/s12885-014-1004-0.

10.

Evaluation and management of patients with heart disease and cancer: cardio-oncology.

Herrmann J, Lerman A, Sandhu NP, Villarraga HR, Mulvagh SL, Kohli M.

Mayo Clin Proc. 2014 Sep;89(9):1287-306. doi: 10.1016/j.mayocp.2014.05.013. Review.

11.

Cardiac effects of anticancer therapy in the elderly.

Accordino MK, Neugut AI, Hershman DL.

J Clin Oncol. 2014 Aug 20;32(24):2654-61. doi: 10.1200/JCO.2013.55.0459. Epub 2014 Jul 28. Review.

12.

Metabolic syndrome in Mexican women survivors of breast cancer: a pilot study at a general hospital.

Ortiz-Mendoza CM, de-la-Fuente-Vera TA, Pérez-Chávez E.

Med Arch. 2014;68(1):19-21.

13.

Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review.

Puts MT, Tu HA, Tourangeau A, Howell D, Fitch M, Springall E, Alibhai SM.

Ann Oncol. 2014 Mar;25(3):564-77. doi: 10.1093/annonc/mdt433. Epub 2013 Nov 26. Review.

14.

Lipid nature and their influence on opening of redox-active liposomes.

Loew M, Forsythe JC, McCarley RL.

Langmuir. 2013 Jun 4;29(22):6615-23. doi: 10.1021/la304340e. Epub 2013 May 22.

15.

Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms.

Cascales A, Pastor-Quirante F, Sánchez-Vega B, Luengo-Gil G, Corral J, Ortuño-Pacheco G, Vicente V, de la Peña FA.

Oncologist. 2013;18(4):446-53. doi: 10.1634/theoncologist.2012-0239. Epub 2013 Apr 10.

16.

Doxorubicin Cardiotoxicity and Cardiac Function Improvement After Stem Cell Therapy Diagnosed by Strain Echocardiography.

Oliveira MS, Melo MB, Carvalho JL, Melo IM, Lavor MS, Gomes DA, de Goes AM, Melo MM.

J Cancer Sci Ther. 2013;5(2):52-57.

17.
18.

Reconsideration of key articles regarding medication-related problems in older adults from 2011.

Thorpe CT, Lassila HC, O'Neil CK, Thorpe JM, Hanlon JT, Maher RL Jr.

Am J Geriatr Pharmacother. 2012 Feb;10(1):2-13. doi: 10.1016/j.amjopharm.2012.01.004. Review. No abstract available.

19.

Senior adult oncology.

Hurria A, Browner IS, Cohen HJ, Denlinger CS, deShazo M, Extermann M, Ganti AK, Holland JC, Holmes HM, Karlekar MB, Keating NL, McKoy J, Medeiros BC, Mrozek E, O'Connor T, Petersdorf SH, Rugo HS, Silliman RA, Tew WP, Walter LC, Weir AB 3rd, Wildes T.

J Natl Compr Canc Netw. 2012 Feb;10(2):162-209. No abstract available.

20.

Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy.

Corazzelli G, Frigeri F, Arcamone M, Lucania A, Rosariavilla M, Morelli E, Amore A, Capobianco G, Caronna A, Becchimanzi C, Volzone F, Marcacci G, Russo F, De Filippi R, Mastrullo L, Pinto A.

Br J Haematol. 2011 Sep;154(5):579-89. doi: 10.1111/j.1365-2141.2011.08786.x. Epub 2011 Jun 28.

Supplemental Content

Support Center